Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating postoperative concurrent chemoradiotherapy with docetaxel for high-risk squamous cell carcinoma of the head and neck has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Conditions: Head-and-neck Cancer, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED